Dexamethasone Sodium Phosphate Injection Shortage
Last Updated: September 5, 2025
Status: Current
Unavailable, Current:
- Dexamethasone Sodium Phosphate, Injection, 100 mg/10 mL (Eugia US LLC)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Eugia US LLC)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
Available, Current:
- Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
- Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (Somerset Therapeutics, LLC)
- Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Eugia US LLC)
- Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
- Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
- Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Mylan Institutional, a Viatris Company)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Mylan Institutional, a Viatris Company)
Dexamethasone Sodium Phosphate, Injection, 100 mg/10 mL (Eugia US LLC)
NDC Code: 55150-305-10Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: On backorder. Recovery: TBD. Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-238-7880
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Eugia US LLC)
NDC Code: 55150-237-01Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: On backorder. Recovery: TBD. Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-238-7880
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Eugia US LLC)
NDC Code: 55150-238-05Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: On backorder. Recovery: TBD. Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-238-7880
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Eugia US LLC)
NDC Code: 55150-239-30Availability: Unavailable
Status: Current
Date of update: September 5, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: On backorder. Recovery: TBD. Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-238-7880
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0641-6146-25Availability: Unavailable
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Additional lots will be available in the April 2025 timeframe. Product will be made available as it is released.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-631-2174
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 76045-106-10Availability: Unavailable
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Reason for shortage: Demand increase for the drug
Related Information: Not available at this time.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (Somerset Therapeutics, LLC)
NDC Code: 70069-021-25Availability: Available
Status: Current
Date of update: August 19, 2025
Update type: Reverified
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 732-554-1019
Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-506-01Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-516-10Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0641-0367-25Availability: Available
Status: Current
Date of update: July 23, 2025
Update type: Reverified
Related Information: Currently available. Additional product will be made available as it is released.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-631-2174
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 76045-109-10Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Eugia US LLC)
NDC Code: 55150-304-25Availability: Available
Status: Current
Date of update: September 5, 2025
Update type: Revised
Related Information: Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-238-7880
Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (Mylan Institutional, a Viatris Company)
NDC Code: 67457-420-10Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-796-9526
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-165-05Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-165-30Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Fresenius Kabi USA, LLC)
NDC Code: 63323-165-01Availability: Available
Status: Current
Date of update: September 2, 2025
Update type: Reverified
Related Information: Check wholesalers for inventory.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 888-386-1300
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Hikma Pharmaceuticals USA, Inc.)
NDC Code: 0641-6145-25Availability: Available
Status: Current
Date of update: July 23, 2025
Update type: Revised
Related Information: Currently available. Additional product will be made available as it is released.
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-631-2174
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Mylan Institutional, a Viatris Company)
NDC Code: 67457-423-12Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-796-9526
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Mylan Institutional, a Viatris Company)
NDC Code: 67457-422-54Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-796-9526
Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (Mylan Institutional, a Viatris Company)
NDC Code: 67457-421-30Availability: Available
Status: Current
Date of update: September 3, 2025
Update type: Reverified
Therapeutic category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology
Initial posting date: February 8, 2019
Contact info: 800-796-9526
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.